MEDACTA GROUP N overview

Medacta Group SA / Key word(s): Annual Results/Annual Results Medacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0% 25-March-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press Release – Ad-hoc announcement pursuant to Art. 53 LR Medacta Group SA reports an excellent performance in 2024 with an adjusted...

Medacta Group SA / Key word(s): Acquisition/Acquisition Medacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed 07.03.2025 / 07:00 CET/CEST Press Release Medacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed Specialist provider of sports medicine and arthroscopy solutions Excellently complementing Medacta’s portfolio in sports medicine Gaining access to additional global sales channels and customers Increasing presence in the fast-growing...

Medacta Group SA / Key word(s): Sales Result Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024 04-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press Release – Ad-hoc announcement pursuant to Art. 53 LR Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency 1 in 2024 FY 2024 revenue accelerated...

Medacta Group SA / Key word(s): Miscellaneous Medacta unveils the extended enhancements to its Hip Revision Platform 21.10.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta unveils the extended enhancements to its Hip Revision Platform CASTEL SAN PIETRO, October 21, 2024—Medacta Group SA ("Medacta," SIX:MOVE) is pleased to announce the further expansion of its comprehensive Hip Revision Platform in the European market, reinforcing its commitment to providing innovative solutions for complex hip...

Medacta Group SA / Key word(s): Miscellaneous Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy 30.09.2024 / 12:00 CET/CEST MEDIA RELEASE Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy CASTEL SAN PIETRO, Switzerland, September 30, 2024 - Medacta Group SA (SIX:MOVE) held its first Capital Markets Day on September 25, 2024, at its headquarters in Switzerland. The event attracted...

Medacta Group SA / Key word(s): Quarter Results Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024. 25-Sep-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press Release – Ad-hoc announcement pursuant to Art. 53 LR Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted...

Medacta Group SA / Key word(s): Miscellaneous Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week 24.09.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week CASTEL SAN PIETRO, September 24, 2024—Medacta Group SA ("Medacta," SIX:MOVE) announced...

Medacta Group SA / Key word(s): Miscellaneous Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow 12.09.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow CASTEL SAN PIETRO, September 12, 2024 - Medacta Group SA ("Medacta,"...